Premium
What is the optimal perioperative management of antiplatelet therapy?
Author(s) -
Shah Ravi R.,
Lalwani Anil K.
Publication year - 2016
Publication title -
the laryngoscope
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.181
H-Index - 148
eISSN - 1531-4995
pISSN - 0023-852X
DOI - 10.1002/lary.25776
Subject(s) - medicine , aspirin , perioperative , myocardial infarction , surgery , coronary artery disease , discontinuation , clopidogrel , randomized controlled trial , platelet aggregation inhibitor , stent , angina , stroke (engine) , unstable angina , coronary artery bypass surgery , cardiology , artery , mechanical engineering , engineering
BACKGROUND A significant proportion of patients undergoing otolaryngological surgery take antiplatelet therapy for a variety of conditions, including coronary artery disease and angina; following cardiac procedures, stroke, or transient ischemic attacks; and peripheral vascular disease. However, continuation of antiplatelet therapy may lead to increased risk of bleeding, whereas discontinuation could cause cardiovascular complications.